PDB Short entry for 2V2W HEADER IMMUNE SYSTEM 07-JUN-07 2V2W TITLE T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR TITLE 2 ENGAGEMENT COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN; COMPND 3 CHAIN: A, D; COMPND 4 FRAGMENT: PEPTIDE BINDING DOMAIN, RESIDUES 25-300; COMPND 5 SYNONYM: HLA-A0201, MHC CLASS I ANTIGEN A*2; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: BETA-2 MICROGLOBULIN; COMPND 9 CHAIN: B, E; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: HIV P17; COMPND 13 CHAIN: C, F; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 13 MOL_ID: 3; SOURCE 14 SYNTHETIC: YES; SOURCE 15 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS; SOURCE 16 ORGANISM_TAXID: 12721 KEYWDS IMMUNOGLOBULIN DOMAIN, COMPLEX (ANTIGEN-PEPTIDE), TCR, HIV, MHC, KEYWDS 2 AIDS, MHC I, HLA-A2, MEMBRANE, HOST-VIRUS INTERACTION, PYRROLIDONE KEYWDS 3 CARBOXYLIC ACID, IMMUNE SYSTEM, UBL CONJUGATION, IMMUNE RESPONSE, KEYWDS 4 DISEASE MUTATION, POLYMORPHISM, GLYCOPROTEIN, TRANSMEMBRANE EXPDTA X-RAY DIFFRACTION AUTHOR J.K.LEE,G.STEWART-JONES,T.DONG,K.HARLOS,K.DI GLERIA,L.DORRELL, AUTHOR 2 D.C.DOUEK,P.A.VAN DER MERWE,E.Y.JONES,A.J.MCMICHAEL REVDAT 3 13-DEC-23 2V2W 1 REMARK REVDAT 2 24-FEB-09 2V2W 1 VERSN REVDAT 1 06-NOV-07 2V2W 0 SPRSDE 06-NOV-07 2V2W 2BSU JRNL AUTH J.K.LEE,G.STEWART-JONES,T.DONG,K.HARLOS,K.DI GLERIA, JRNL AUTH 2 L.DORRELL,D.C.DOUEK,P.A.VAN DER MERWE,E.Y.JONES, JRNL AUTH 3 A.J.MCMICHAEL JRNL TITL T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING JRNL TITL 2 TCR ENGAGEMENT. JRNL REF J.EXP.MED. V. 200 1455 2004 JRNL REFN ISSN 0022-1007 JRNL PMID 15583017 JRNL DOI 10.1084/JEM.20041251 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 72.55 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 86.5 REMARK 3 NUMBER OF REFLECTIONS : 96149 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5052 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.64 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3175 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3100 REMARK 3 BIN FREE R VALUE SET COUNT : 158 REMARK 3 BIN FREE R VALUE : 0.3550 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6212 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 1257 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.06000 REMARK 3 B22 (A**2) : -0.06000 REMARK 3 B33 (A**2) : -0.60000 REMARK 3 B12 (A**2) : 0.59000 REMARK 3 B13 (A**2) : 0.43000 REMARK 3 B23 (A**2) : 0.49000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.114 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.113 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.072 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.033 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.938 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6392 ; 0.013 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8676 ; 1.386 ; 1.923 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 762 ; 6.034 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 332 ;31.848 ;23.012 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1016 ;14.174 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 54 ;17.758 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 882 ; 0.103 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5036 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2946 ; 0.206 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4275 ; 0.296 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 932 ; 0.147 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 52 ; 0.118 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 70 ; 0.165 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3924 ; 0.954 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 6114 ; 1.509 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2909 ; 2.296 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2562 ; 3.469 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2V2W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-JUN-07. REMARK 100 THE DEPOSITION ID IS D_1290032835. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 101204 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.5 REMARK 200 DATA REDUNDANCY : 1.900 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 41.1 REMARK 200 DATA REDUNDANCY IN SHELL : 1.80 REMARK 200 R MERGE FOR SHELL (I) : 0.40000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.760 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: PDB ENTRY 1HHI REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 4860 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 4920 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 17 CB CG CD NE CZ NH1 NH2 REMARK 470 GLN A 54 CB CG CD OE1 NE2 REMARK 470 GLU A 177 CB CG CD OE1 OE2 REMARK 470 HIS A 192 CB CG ND1 CD2 CE1 NE2 REMARK 470 ASP A 223 CB CG OD1 OD2 REMARK 470 PRO A 276 CA C O CB CG CD REMARK 470 GLU B 44 CB CG CD OE1 OE2 REMARK 470 GLU B 47 CB CG CD OE1 OE2 REMARK 470 LYS B 58 CB CG CD CE NZ REMARK 470 GLU B 74 CB CG CD OE1 OE2 REMARK 470 ARG D 17 CB CG CD NE CZ NH1 NH2 REMARK 470 GLN D 54 CB CG CD OE1 NE2 REMARK 470 GLU D 177 CB CG CD OE1 OE2 REMARK 470 HIS D 192 CB CG ND1 CD2 CE1 NE2 REMARK 470 ASP D 223 CB CG OD1 OD2 REMARK 470 PRO D 276 CA C O CB CG CD REMARK 470 GLU E 44 CB CG CD OE1 OE2 REMARK 470 GLU E 47 CB CG CD OE1 OE2 REMARK 470 LYS E 58 CB CG CD CE NZ REMARK 470 GLU E 74 CB CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CA GLU E 47 O HOH E 2147 1.98 REMARK 500 OE1 GLU A 58 O HOH A 2116 2.15 REMARK 500 O SER A 251 O HOH A 2365 2.16 REMARK 500 O HIS A 197 O HOH A 2306 2.16 REMARK 500 OXT LEU C 9 O HOH C 2018 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 -130.90 51.26 REMARK 500 VAL A 194 -76.68 -70.31 REMARK 500 SER A 195 -157.77 -107.67 REMARK 500 GLU A 275 23.37 -144.12 REMARK 500 TRP B 60 -6.47 82.67 REMARK 500 ASP D 29 -126.20 52.90 REMARK 500 TRP E 60 -7.52 81.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2032 DISTANCE = 6.14 ANGSTROMS REMARK 525 HOH C2003 DISTANCE = 6.15 ANGSTROMS REMARK 525 HOH D2030 DISTANCE = 6.97 ANGSTROMS REMARK 525 HOH E2043 DISTANCE = 6.36 ANGSTROMS REMARK 525 HOH E2044 DISTANCE = 6.29 ANGSTROMS REMARK 525 HOH E2045 DISTANCE = 6.51 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AKJ RELATED DB: PDB REMARK 900 COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 ANDTHE T CELL REMARK 900 CORECEPTOR CD8 REMARK 900 RELATED ID: 1AO7 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA- REMARK 900 A 0201 REMARK 900 RELATED ID: 1AQD RELATED DB: PDB REMARK 900 HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITYPROTEIN REMARK 900 (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUSPEPTIDE REMARK 900 RELATED ID: 1B0G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HUMAN PEPTIDE P1049 REMARK 900 RELATED ID: 1B0R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201 COMPLEXED WITH A PEPTIDE WITH THE REMARK 900 CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP REMARK 900 RELATED ID: 1BD2 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND REMARK 900 MHC CLASS I MOLECULE HLA-A 0201 REMARK 900 RELATED ID: 1DUY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201/OCTAMERIC TAX PEPTIDE COMPLEX REMARK 900 RELATED ID: 1DUZ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) INCOMPLEX REMARK 900 WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN REMARK 900 RELATED ID: 1EEY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TOPEPTIDE GP2 REMARK 900 WITH THE SUBSTITUTION (I2L/V5L/L9V) REMARK 900 RELATED ID: 1EEZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TOGP2 PEPTIDE REMARK 900 VARIANT(I2L/V5L) REMARK 900 RELATED ID: 1HHG RELATED DB: PDB REMARK 900 RELATED ID: 1HHH RELATED DB: PDB REMARK 900 RELATED ID: 1HHI RELATED DB: PDB REMARK 900 RELATED ID: 1HHJ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEX WITH REMARK 900 A NONAMERIC PEPTIDE FROM HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309- REMARK 900 317) REMARK 900 RELATED ID: 1HHK RELATED DB: PDB REMARK 900 RELATED ID: 1HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2 ( HLA-A2, HUMAN REMARK 900 LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1I1F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 1I1Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 1I4F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4- PEPTIDE COMPLEX REMARK 900 RELATED ID: 1I7R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1058 REMARK 900 RELATED ID: 1I7T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-5V REMARK 900 RELATED ID: 1I7U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-6V REMARK 900 RELATED ID: 1IM3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2BOUND TO REMARK 900 THE MHC CLASS I MOLECULE HLA-A2/TAX REMARK 900 RELATED ID: 1JF1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ADECAMERIC ALTERED REMARK 900 PEPTIDE LIGAND FROM THE MART-1/MELAN-A REMARK 900 RELATED ID: 1JHT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ANONAMERIC ALTERED REMARK 900 PEPTIDE LIGAND (ALGIGILTV) FROM THE MART-1/MELAN-A. REMARK 900 RELATED ID: 1LP9 RELATED DB: PDB REMARK 900 XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1 REMARK 900 RELATED ID: 1OGA RELATED DB: PDB REMARK 900 A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR REMARK 900 RECOGNITION. REMARK 900 RELATED ID: 1P7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR- 1, A HOST ANDVIRAL MHC REMARK 900 RECEPTOR REMARK 900 RELATED ID: 1QEW RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201)COMPLEX WITH REMARK 900 A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATEDANTIGEN 3 (RESIDUES 271- REMARK 900 279) REMARK 900 RELATED ID: 1QR1 RELATED DB: PDB REMARK 900 POOR BINDING OF A HER-2/NEU EPITOPE (GP2 ) TO HLA-A2.1 IS DUE TO A REMARK 900 LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE REMARK 900 RELATED ID: 1QRN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO REMARK 900 ALTERED HTLV-1 TAX PEPTIDE P6A REMARK 900 RELATED ID: 1QSE RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN A6-TCR BOUND TO HLA- A2 COMPLEXED WITH ALTERED REMARK 900 HTLV-1 TAX PEPTIDE V7R REMARK 900 RELATED ID: 1QSF RELATED DB: PDB REMARK 900 STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 REMARK 900 TAX PEPTIDE Y8A REMARK 900 RELATED ID: 1S8D RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDEVARIANTS REMARK 900 BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3A REMARK 900 RELATED ID: 1S9W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC,IN REMARK 900 COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1S9X RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQA, REMARK 900 IN COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1S9Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQS, REMARK 900 IN COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1T1W RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDEVARIANTS REMARK 900 BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3F6I8V REMARK 900 RELATED ID: 1T1X RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDEVARIANTS REMARK 900 BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-4L REMARK 900 RELATED ID: 1T1Y RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDEVARIANTS REMARK 900 BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-5V REMARK 900 RELATED ID: 1T1Z RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDEVARIANTS REMARK 900 BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6A REMARK 900 RELATED ID: 1T20 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDEVARIANTS REMARK 900 BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6I REMARK 900 RELATED ID: 1T21 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDEVARIANTS REMARK 900 BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, MONOCLINICCRYSTAL REMARK 900 RELATED ID: 1T22 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDEVARIANTS REMARK 900 BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9,ORTHORHOMBIC CRYSTAL REMARK 900 RELATED ID: 1TVB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100( 209-217) BOUNDTO HUMAN REMARK 900 CLASS I MHC HLA- A2 REMARK 900 RELATED ID: 1TVH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND REMARK 900 TO HUMAN CLASS I MHC HLA-A2 REMARK 900 RELATED ID: 1UR7 RELATED DB: PDB REMARK 900 MOLECULAR REFINEMENT OF ANTI-HLA-A2 USING LIGHT CHAIN SHUFFLING: A REMARK 900 STRUCTURAL MODEL FOR HLA ANTIBODY BINDING REMARK 900 RELATED ID: 2AV1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC REMARK 900 HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THEHEAVY CHAIN. REMARK 900 RELATED ID: 2AV7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC REMARK 900 HLA-A2 WITH THE K66A MUTATION IN THE HEAVYCHAIN. REMARK 900 RELATED ID: 2BNQ RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL REMARK 900 VACCINES REMARK 900 RELATED ID: 2BNR RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL REMARK 900 VACCINES REMARK 900 RELATED ID: 2BSU RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT REMARK 900 RELATED ID: 2BSV RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT REMARK 900 RELATED ID: 2C7U RELATED DB: PDB REMARK 900 CONFLICTING SELECTIVE FORCES AFFECT CD8 T- CELL RECEPTOR CONTACT REMARK 900 SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE. REMARK 900 RELATED ID: 2CLR RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEXED REMARK 900 WITH A DECAMERIC PEPTIDE FROM CALRETICULIN REMARK 900 RELATED ID: 2GJ6 RELATED DB: PDB REMARK 900 THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2WITH THE REMARK 900 MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRICACID) PEPTIDE REMARK 900 RELATED ID: 2JCC RELATED DB: PDB REMARK 900 AH3 RECOGNITION OF MUTANT HLA-A2 W167A REMARK 900 RELATED ID: 2UWE RELATED DB: PDB REMARK 900 LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION REMARK 900 RELATED ID: 3HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2. 1 (HLA-A2.1 HUMAN REMARK 900 LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1A1M RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDETYPDINQML FROM REMARK 900 GAG PROTEIN OF HIV2 REMARK 900 RELATED ID: 1A1N RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTYFROM THE REMARK 900 NEF PROTEIN (75- 82) OF HIV1 REMARK 900 RELATED ID: 1A1O RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) REMARK 900 FROM THE MALARIA PARASITE P. FALCIPARUM REMARK 900 RELATED ID: 1A6Z RELATED DB: PDB REMARK 900 HFE (HUMAN) HEMOCHROMATOSIS PROTEIN REMARK 900 RELATED ID: 1A9B RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE REMARK 900 TO NONSTANDARD POSITIONING OF THE C-TERMINUS REMARK 900 RELATED ID: 1A9E RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE REMARK 900 TO NONSTANDARD POSITIONING OF THE C-TERMINUS REMARK 900 RELATED ID: 1AGB RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGRKKYKL - 3R MUTATION) REMARK 900 RELATED ID: 1AGC RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYQL - 7Q MUTATION) REMARK 900 RELATED ID: 1AGD RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYKL - INDEX PEPTIDE) REMARK 900 RELATED ID: 1AGE RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYRL - 7R MUTATION) REMARK 900 RELATED ID: 1AGF RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKRYKL - 5R MUTATION) REMARK 900 RELATED ID: 1C16 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/ DELTA T CELL LIGAND T22 REMARK 900 RELATED ID: 1CE6 RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUSNUCLEOPROTEIN PEPTIDE REMARK 900 RELATED ID: 1CG9 RELATED DB: PDB REMARK 900 COMPLEX RECOGNITION OF THE SUPERTYPIC BW6- DETERMINANT ONHLA-B AND- REMARK 900 C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6 REMARK 900 RELATED ID: 1DE4 RELATED DB: PDB REMARK 900 HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRINRECEPTOR REMARK 900 RELATED ID: 1E27 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV REMARK 900 IMMUNODOMINANT EPITOPE KM1 (LPPVVAKEI) REMARK 900 RELATED ID: 1E28 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV REMARK 900 IMMUNODOMINANT EPITOPE KM2 (TAFTIPSI) REMARK 900 RELATED ID: 1EFX RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL REMARK 900 RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3 REMARK 900 RELATED ID: 1EXU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR REMARK 900 RELATED ID: 1GZP RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH GM2 GANGLIOSIDE REMARK 900 RELATED ID: 1GZQ RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL REMARK 900 RELATED ID: 1HSA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA- B(ASTERISK)2705 REMARK 900 RELATED ID: 1HSB RELATED DB: PDB REMARK 900 CLASS I HISTOCOMPATIBILITY ANTIGEN AW68.1 ( LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1IM9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELLINHIBITORY REMARK 900 RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4 REMARK 900 RELATED ID: 1JGD RELATED DB: PDB REMARK 900 HLA-B*2709 BOUND TO DECA-PEPTIDE S10R REMARK 900 RELATED ID: 1JGE RELATED DB: PDB REMARK 900 HLA-B*2705 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1JNJ RELATED DB: PDB REMARK 900 NMR SOLUTION STRUCTURE OF THE HUMAN BETA2- MICROGLOBULIN REMARK 900 RELATED ID: 1K5N RELATED DB: PDB REMARK 900 HLA-B*2709 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1KPR RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1KTL RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1LDS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MONOMERIC HUMAN BETA-2 -MICROGLOBULIN REMARK 900 RELATED ID: 1M05 RELATED DB: PDB REMARK 900 HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT REMARK 900 RELATED ID: 1M6O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLADPA*0201 PEPTIDE REMARK 900 RELATED ID: 1MHE RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1MI5 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBVPEPTIDE REMARK 900 COMPLEX REMARK 900 RELATED ID: 1N2R RELATED DB: PDB REMARK 900 A NATURAL SELECTED DIMORPHISM IN HLA B*44 ALTERS SELF,PEPTIDE REMARK 900 REPORTOIRE AND T CELL RECOGNITION. REMARK 900 RELATED ID: 1OF2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE REMARK 900 INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400- REMARK 900 408 ) REMARK 900 RELATED ID: 1OGT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE REMARK 900 INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400- REMARK 900 408 ) REMARK 900 RELATED ID: 1ONQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE REMARK 900 RELATED ID: 1PY4 RELATED DB: PDB REMARK 900 BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS FOR AMYLOIDFORMATIONS REMARK 900 RELATED ID: 1Q94 RELATED DB: PDB REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND REMARK 900 DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE REMARK 900 ANCHOR RESIDUE REMARK 900 RELATED ID: 1QLF RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G REMARK 900 RELATED ID: 1QQD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER REMARK 900 CELL INHIBITORY RECEPTOR REMARK 900 RELATED ID: 1QVO RELATED DB: PDB REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND REMARK 900 DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE REMARK 900 ANCHOR RESIDUE REMARK 900 RELATED ID: 1R3H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF T10 REMARK 900 RELATED ID: 1SYS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY REMARK 900 RELATED ID: 1SYV RELATED DB: PDB REMARK 900 HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF REMARK 900 RELATED ID: 1TMC RELATED DB: PDB REMARK 900 TRUNCATED HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-AW68 REMARK 900 COMPLEXED WITH A DECAMERIC PEPTIDE (EVAPPEYHRK) REMARK 900 RELATED ID: 1UQS RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL REMARK 900 GLYCOLIPID REMARK 900 RELATED ID: 1UXS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE REMARK 900 PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS REMARK 900 RELATED ID: 1UXW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE REMARK 900 PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS REMARK 900 RELATED ID: 1VGK RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITYCOMPLEX, H- REMARK 900 2KD AT 2.0 A RESOLUTION REMARK 900 RELATED ID: 1W0V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS REMARK 900 FROM EGF- RESPONSE FACTOR 1 REMARK 900 RELATED ID: 1W0W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS REMARK 900 FROM EGF- RESPONSE FACTOR 1 REMARK 900 RELATED ID: 1W72 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3 REMARK 900 RELATED ID: 1X7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSIDPEPTIDE REMARK 900 RELATED ID: 1XH3 RELATED DB: PDB REMARK 900 CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERICPEPTIDES IN REMARK 900 COMPLEX WITH HLA-B* 3501 REMARK 900 RELATED ID: 1XR8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN REMARK 900 UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 REMARK 900 RELATED ID: 1XR9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN REMARK 900 UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 REMARK 900 RELATED ID: 1XZ0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETICMYCOBACTIN REMARK 900 LIPOPEPTIDE REMARK 900 RELATED ID: 1YDP RELATED DB: PDB REMARK 900 1.9A CRYSTAL STRUCTURE OF HLA-G REMARK 900 RELATED ID: 1YPZ RELATED DB: PDB REMARK 900 IMMUNE RECEPTOR REMARK 900 RELATED ID: 1ZS8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 REMARK 900 RELATED ID: 1ZSD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBVANTIGEN REMARK 900 EPLPQGQLTAY REMARK 900 RELATED ID: 1ZT4 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA- REMARK 900 GALACTOSYLCERAMIDE REMARK 900 RELATED ID: 2A83 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGONRECEPTOR REMARK 900 (GR) PEPTIDE ( RESIDUES 412-420) REMARK 900 RELATED ID: 2AK4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508-13MER REMARK 900 PEPTIDE REMARK 900 RELATED ID: 2AXF RELATED DB: PDB REMARK 900 THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED REMARK 900 BY ITS MHC-BOUND CONFORMATION REMARK 900 RELATED ID: 2AXG RELATED DB: PDB REMARK 900 THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED REMARK 900 BY ITS MHC-BOUND CONFORMATION REMARK 900 RELATED ID: 2BCK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASEPEPTIDE REMARK 900 RELATED ID: 2BSR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 2BSS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 2BST RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 2BVQ RELATED DB: PDB REMARK 900 STRUCTURES OF THREE HIV-1 HLA-B5703- PEPTIDE COMPLEXES AND REMARK 900 IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG - REMARK 900 TERM NON-PROGRESSION REMARK 900 RELATED ID: 2CII RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED WITH A PARTIAL PEPTIDE REMARK 900 EPITOPE SUGGESTS AN MHC CLASS I ASSEMBLY-INTERMEDIATE REMARK 900 RELATED ID: 2CIK RELATED DB: PDB REMARK 900 INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE REMARK 900 STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM REMARK 900 CYTOCHROME P450. REMARK 900 RELATED ID: 2D31 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER REMARK 900 RELATED ID: 2ESV RELATED DB: PDB REMARK 900 STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX REMARK 900 RELATED ID: 2F74 RELATED DB: PDB REMARK 900 MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND REMARK 900 LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33 REMARK 900 RELATED ID: 2F8O RELATED DB: PDB REMARK 900 A NATIVE TO AMYLOIDOGENIC TRANSITION REGULATED BY ABACKBONE TRIGGER REMARK 900 RELATED ID: 2H26 RELATED DB: PDB REMARK 900 HUMAN CD1B IN COMPLEX WITH ENDOGENOUS PHOSPHATIDYLCHOLINEAND SPACER REMARK 900 RELATED ID: 2HJK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE REMARK 900 RELATED ID: 2HJL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE REMARK 900 RELATED ID: 2HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN AW 68.1 (HLA-AW 68.1, REMARK 900 HUMAN LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 2V2X RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT. DBREF 2V2W A 1 276 UNP P01892 1A02_HUMAN 25 300 DBREF 2V2W B 0 0 PDB 2V2W 2V2W 0 0 DBREF 2V2W B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 2V2W C 1 9 PDB 2V2W 2V2W 1 9 DBREF 2V2W D 1 276 UNP P01892 1A02_HUMAN 25 300 DBREF 2V2W E 0 0 PDB 2V2W 2V2W 0 0 DBREF 2V2W E 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 2V2W F 1 9 PDB 2V2W 2V2W 1 9 SEQRES 1 A 276 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 A 276 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 A 276 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 276 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 A 276 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 A 276 LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 A 276 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 A 276 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 A 276 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 A 276 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 A 276 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 A 276 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 A 276 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 A 276 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 A 276 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 A 276 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 A 276 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 A 276 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 A 276 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 A 276 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 A 276 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 A 276 TRP GLU PRO SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 9 SER LEU TYR ASN THR VAL ALA THR LEU SEQRES 1 D 276 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 D 276 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 D 276 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 D 276 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 D 276 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 D 276 LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 D 276 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 D 276 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 D 276 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 D 276 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 D 276 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 D 276 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 D 276 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 D 276 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 D 276 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 D 276 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 D 276 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 D 276 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 D 276 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 D 276 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 D 276 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 D 276 TRP GLU PRO SEQRES 1 E 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 E 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 E 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 E 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 E 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 E 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 E 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 E 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 F 9 SER LEU TYR ASN THR VAL ALA THR LEU FORMUL 7 HOH *1257(H2 O) HELIX 1 1 ALA A 49 GLU A 55 5 7 HELIX 2 2 GLY A 56 TYR A 85 1 30 HELIX 3 3 ASP A 137 ALA A 150 1 14 HELIX 4 4 HIS A 151 GLY A 162 1 12 HELIX 5 5 GLY A 162 GLY A 175 1 14 HELIX 6 6 GLY A 175 GLN A 180 1 6 HELIX 7 7 THR A 225 THR A 228 5 4 HELIX 8 8 GLN A 253 GLN A 255 5 3 HELIX 9 9 ALA D 49 GLU D 53 5 5 HELIX 10 10 GLY D 56 TYR D 85 1 30 HELIX 11 11 ASP D 137 ALA D 150 1 14 HELIX 12 12 HIS D 151 GLY D 162 1 12 HELIX 13 13 GLY D 162 GLY D 175 1 14 HELIX 14 14 GLY D 175 GLN D 180 1 6 HELIX 15 15 THR D 225 THR D 228 5 4 HELIX 16 16 GLN D 253 GLN D 255 5 3 SHEET 1 AA 8 GLU A 46 PRO A 47 0 SHEET 2 AA 8 THR A 31 ASP A 37 -1 O ARG A 35 N GLU A 46 SHEET 3 AA 8 ARG A 21 VAL A 28 -1 O ALA A 24 N PHE A 36 SHEET 4 AA 8 HIS A 3 VAL A 12 -1 O ARG A 6 N TYR A 27 SHEET 5 AA 8 THR A 94 VAL A 103 -1 O VAL A 95 N SER A 11 SHEET 6 AA 8 PHE A 109 TYR A 118 -1 N LEU A 110 O ASP A 102 SHEET 7 AA 8 LYS A 121 LEU A 126 -1 O LYS A 121 N TYR A 118 SHEET 8 AA 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 AB 4 LYS A 186 ALA A 193 0 SHEET 2 AB 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AB 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208 SHEET 4 AB 4 GLU A 229 LEU A 230 -1 O GLU A 229 N ALA A 246 SHEET 1 AC 4 LYS A 186 ALA A 193 0 SHEET 2 AC 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AC 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208 SHEET 4 AC 4 ARG A 234 PRO A 235 -1 O ARG A 234 N GLN A 242 SHEET 1 AD 4 GLU A 222 ASP A 223 0 SHEET 2 AD 4 THR A 214 ARG A 219 -1 O ARG A 219 N GLU A 222 SHEET 3 AD 4 TYR A 257 GLN A 262 -1 O THR A 258 N GLN A 218 SHEET 4 AD 4 LEU A 270 LEU A 272 -1 O LEU A 270 N VAL A 261 SHEET 1 BA 4 LYS B 6 SER B 11 0 SHEET 2 BA 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 BA 4 PHE B 62 PHE B 70 -1 O PHE B 62 N PHE B 30 SHEET 4 BA 4 GLU B 50 HIS B 51 -1 O GLU B 50 N TYR B 67 SHEET 1 BB 4 LYS B 6 SER B 11 0 SHEET 2 BB 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 BB 4 PHE B 62 PHE B 70 -1 O PHE B 62 N PHE B 30 SHEET 4 BB 4 SER B 55 PHE B 56 -1 O SER B 55 N TYR B 63 SHEET 1 BC 4 GLU B 44 ARG B 45 0 SHEET 2 BC 4 GLU B 36 LYS B 41 -1 O LYS B 41 N GLU B 44 SHEET 3 BC 4 TYR B 78 ASN B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 BC 4 LYS B 91 LYS B 94 -1 O LYS B 91 N VAL B 82 SHEET 1 DA 8 GLU D 46 PRO D 47 0 SHEET 2 DA 8 THR D 31 ASP D 37 -1 O ARG D 35 N GLU D 46 SHEET 3 DA 8 ARG D 21 VAL D 28 -1 O ALA D 24 N PHE D 36 SHEET 4 DA 8 HIS D 3 VAL D 12 -1 O ARG D 6 N TYR D 27 SHEET 5 DA 8 THR D 94 VAL D 103 -1 O VAL D 95 N SER D 11 SHEET 6 DA 8 PHE D 109 TYR D 118 -1 N LEU D 110 O ASP D 102 SHEET 7 DA 8 LYS D 121 LEU D 126 -1 O LYS D 121 N TYR D 118 SHEET 8 DA 8 TRP D 133 ALA D 135 -1 O THR D 134 N ALA D 125 SHEET 1 DB 4 LYS D 186 ALA D 193 0 SHEET 2 DB 4 GLU D 198 PHE D 208 -1 O THR D 200 N HIS D 192 SHEET 3 DB 4 PHE D 241 PRO D 250 -1 O PHE D 241 N PHE D 208 SHEET 4 DB 4 GLU D 229 LEU D 230 -1 O GLU D 229 N ALA D 246 SHEET 1 DC 4 LYS D 186 ALA D 193 0 SHEET 2 DC 4 GLU D 198 PHE D 208 -1 O THR D 200 N HIS D 192 SHEET 3 DC 4 PHE D 241 PRO D 250 -1 O PHE D 241 N PHE D 208 SHEET 4 DC 4 ARG D 234 PRO D 235 -1 O ARG D 234 N GLN D 242 SHEET 1 DD 4 GLU D 222 ASP D 223 0 SHEET 2 DD 4 THR D 214 ARG D 219 -1 O ARG D 219 N GLU D 222 SHEET 3 DD 4 TYR D 257 GLN D 262 -1 O THR D 258 N GLN D 218 SHEET 4 DD 4 LEU D 270 LEU D 272 -1 O LEU D 270 N VAL D 261 SHEET 1 EA 7 LYS E 6 SER E 11 0 SHEET 2 EA 7 ASN E 21 PHE E 30 -1 O ASN E 24 N TYR E 10 SHEET 3 EA 7 PHE E 62 PHE E 70 -1 O PHE E 62 N PHE E 30 SHEET 4 EA 7 GLU E 50 HIS E 51 -1 O GLU E 50 N TYR E 67 SHEET 5 EA 7 PHE E 62 PHE E 70 -1 O TYR E 67 N GLU E 50 SHEET 6 EA 7 SER E 55 PHE E 56 -1 O SER E 55 N TYR E 63 SHEET 7 EA 7 PHE E 62 PHE E 70 -1 O TYR E 63 N SER E 55 SHEET 1 EB 4 GLU E 44 ARG E 45 0 SHEET 2 EB 4 GLU E 36 LYS E 41 -1 O LYS E 41 N GLU E 44 SHEET 3 EB 4 TYR E 78 ASN E 83 -1 O ALA E 79 N LEU E 40 SHEET 4 EB 4 LYS E 91 LYS E 94 -1 O LYS E 91 N VAL E 82 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.07 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.04 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.06 SSBOND 4 CYS D 101 CYS D 164 1555 1555 2.04 SSBOND 5 CYS D 203 CYS D 259 1555 1555 2.05 SSBOND 6 CYS E 25 CYS E 80 1555 1555 2.06 CISPEP 1 TYR A 209 PRO A 210 0 0.72 CISPEP 2 HIS B 31 PRO B 32 0 -2.62 CISPEP 3 TYR D 209 PRO D 210 0 1.08 CISPEP 4 HIS E 31 PRO E 32 0 0.93 CRYST1 50.772 63.605 74.988 81.98 76.26 77.85 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019696 -0.004240 -0.004436 0.00000 SCALE2 0.000000 0.016082 -0.001523 0.00000 SCALE3 0.000000 0.000000 0.013790 0.00000